CA - DiaMedica Therapeutics Inc. (DMAC) Q1 2024 Earnings Call Transcript

2024-05-11 16:49:05 ET

DiaMedica Therapeutics Inc. (DMAC)

Q1 2024 Results Conference Call

May 9, 2024 08:00 AM ET

Company Participants

Rick Pauls - President, CEO & Director

Lorianne Masuoka - Chief Medical Officer

Scott Kellen - CFO & Company Secretary

Conference Call Participants

Chase Knickerbocker - Craig-Hallum

Thomas Flaten - Lake Street

François Brisebois - Oppenheimer

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2024 Conference Call.

An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investor Relations section. Before the company proceeds with its remarks, please note that the company will be making forward-looking statements on today's call.

These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these statements. More information, including factors that could cause actual results to differ from projected results appears in the section entitled Cautionary Statement Note regarding forward-looking statements in the company's press release issued yesterday and under the heading Risk Factors in DiaMedica's most recent annual report on Form 10-K and current year quarterly reports on Form 10-Q....

For further details see: